An Australian biotech company is already turning heads so far on Wednesday after it was announced results from its GBM-AGILE, which is a phase II/III study that included an...

To read the full story on AllPennyStocks.com, click here.

Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Kazia Therapeutics Charts.
Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Kazia Therapeutics Charts.